HBsAg-positive for more than 6 months (HBeAg-positive or HBeAg-negative).
Age > 20 y/o.
Under lamivudine/adefovir treatment for more than 1 year due to previous lamivudine resistance (LAM-R), current HBV DNA is undetectable (< 20 IU/ml) during enrollment.
